Information  X 
Enter a valid email address

EPIC/TIDM matching 'SUMM'

Date
Time Source
Company
Announcement
24 Feb 2020 7:00 am RNS   AIM Cancellation - Summit Therapeutics PLC
17 Feb 2020 5:30 pm RNS   FTSE Russell Summit Therapeutics
11 Feb 2020 10:00 am GNW Factsheet Summit Therapeutics plc (SUMM) AIM Delisting Reminder
10 Feb 2020 2:15 pm GNW Factsheet Summit Therapeutics plc (SUMM) Director/PDMR Shareholding
06 Feb 2020 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma
04 Feb 2020 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Present at the 2020 BIO CEO & Investor Conference
27 Jan 2020 7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Exercise of Restricted Stock Units
24 Jan 2020 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Announces Management Update
23 Jan 2020 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work
20 Jan 2020 2:15 pm GNW Factsheet Summit Therapeutics plc (SUMM) Holding(s) in Company
  2:15 pm GNW Factsheet Summit Therapeutics plc (SUMM) Holding(s) in Company
15 Jan 2020 12:15 pm GNW Factsheet Summit Therapeutics plc (SUMM) Notification of Transactions of Persons Discharging Managerial Responsibilities
07 Jan 2020 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection
31 Dec 2019 9:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Holding(s) in Company
30 Dec 2019 7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Holding(s) in Company
24 Dec 2019 8:30 am GNW Factsheet Summit Therapeutics plc (SUMM) Completion of $50 million Fundraising and Directorate Change
  7:01 am GNW Factsheet Summit Therapeutics plc (SUMM) Award of Share Options
  7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Exercise of Restricted Stock Units
23 Dec 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Result of General Meeting
19 Dec 2019 7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Timetable Update
17 Dec 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended 31 October 2019
16 Dec 2019 2:15 pm GNW Factsheet Summit Therapeutics plc (SUMM) Notice of Q3 Results
06 Dec 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Announces a Proposed Subscription and Placing to Raise approximately $50.0 Million and Notice of General Meeting
06 Nov 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance Congress
04 Nov 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics Recognises C. difficile Awareness Month
16 Oct 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Present at the 2019 BIO Investor Forum
11 Oct 2019 12:01 pm GNW Factsheet Summit Therapeutics plc (SUMM) Directorate change
  12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Half-year report
10 Oct 2019 2:30 pm GNW Factsheet Summit Therapeutics plc (SUMM) Notice of Results
07 Oct 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection
03 Oct 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics Reports Ridinilazole Significantly Improved Short and Longer-Term Quality of Life Measures in Patients with C. difficile Infection Compared to Standard of Care
  7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Block Listing Six Month Review
01 Oct 2019 2:05 pm RNS Factsheet Summit Therapeutics (SUMM) Second Price Monitoring Extn
  2:00 pm RNS Factsheet Summit Therapeutics (SUMM) Price Monitoring Extension
25 Sep 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Host R&D Day 7 October 2019
24 Sep 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Present Data from Phase 2 Clinical Trial of Ridinilazole at ID Week 2019
18 Sep 2019 7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient Outcomes
05 Sep 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID Conference
04 Sep 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Participate in Upcoming Investor Conferences
01 Aug 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
17 Jul 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Highlighted Potential of SMT-571 to Combat the Rising Global Health Threat of Gonorrhoea at STI & HIV World Congress
09 Jul 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit’s DDS-04 Enterobacteriaceae Programme Demonstrates In Vivo Efficacy in Sepsis and Pneumonia
20 Jun 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019
19 Jun 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Result of AGM
18 Jun 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Increased BARDA Award and Option Exercise
12 Jun 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019
05 Jun 2019 2:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Notice of First Quarter Results
14 May 2019 5:30 pm GNW Factsheet Summit Therapeutics plc (SUMM) UK Annual Report and Notice of AGM
29 Apr 2019 12:30 pm GNW Factsheet Summit Therapeutics plc (SUMM) Block Listing Interim Review
24 Apr 2019 4:20 pm GNW Factsheet Summit Therapeutics plc (SUMM) Exercise of Restricted Stock Units
15 Apr 2019 7:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019
03 Apr 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
02 Apr 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
29 Mar 2019 5:45 pm GNW Factsheet Summit Therapeutics plc (SUMM) Award of Share Options
  11:15 am GNW Factsheet Summit Therapeutics plc (SUMM) Filing of Annual Report on Form 20-F
27 Mar 2019 11:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Final Results
25 Mar 2019 11:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Notice of Results
18 Mar 2019 11:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Summit Therapeutics to Present at Upcoming Conferences
14 Mar 2019 11:00 am GNW Factsheet Summit Therapeutics plc (SUMM) Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR Diagnostics 2019 Conference
25 Feb 2019 12:00 pm GNW Factsheet Summit Therapeutics plc (SUMM) Summit’s SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data


Company Announcements Archive »


a d v e r t i s e m e n t